Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
PharmaLogic Holdings Corp., a contract development and manufacturing organization (CDMO) and radiopharmacy solutions provider, announced the opeing of its radiopharmaceutical production and research facility in the Bronx, New York.
read more
Science 37 Holdings, Inc. announced the preliminary outcome of its recent FDA Inspection focusing on critical areas and documentation. The nearly two-week review included, but was not limited to, the Science 37 Metasite™ model and internal processes,...
read more
Allucent, a global mid-sized clinical research organization (CRO), announced that it received a project award valued at $25.5 million through the Rapid Response Partnership Vehicle (RRPV) Consortium to conduct its Decentralized Home Focus COVID-19 ...
read more
Icosagen, a CRDMO with expertise in innovative antibody research and production, announced a strategic partnership on selected projects with Lead Discovery Center GmbH (LDC), a translational drug discovery organization tapping on a broad network in ...
read more
Dr. Vince Clinical Research (DVCR), a full-service contract research organization (CRO), announced the appointment of Sheldon Preskorn, M.D., as its Senior Vice President of Neuroscience.
read more
ERS Genomics Limited announced a non-exclusive CRISPR/Cas9 license agreement. The agreement grants IRBM access to ERS’ CRISPR/Cas9 patent portfolio.
read more
The leading US multi-specialty healthcare center, Metrodora Institute, and pioneering precision medicine company, PrecisionLife, announce the start of recruitment on a cohort of up to 1,000 patients into clinical trials to evaluate new diagnosis and ...
read more
AGC Biologics and BioConnection have announced a new strategic partnership. The companies are partnering to provide end- to-end biopharmaceutical development and manufacturing capabilities for drug substance and drug product using the development and...
read more
Cannovation Clinical Research Partners, a pioneering Cannabis-Based Clinical Research Organization for Drug and Product Development, is proudly announcing its official launch, marking a significant milestone in pharmaceutical and biotech innovation.
read more
Rentschler Biopharma SE announced that Patrick Meyer, Ph.D., has been promoted to Global Head BD Sales and Alliance Management within the business development team, effective June 1, 2024. In this newly created position, Dr. Meyer will oversee global...
read more
Berkshire Sterile Manufacturing (BSM), the Sterile Division of Sharp, announced the appointment of James Hamilton as the new President. This transition comes as Shawn Kinney steps down from his role as President to retire, but he will remain on staff...
read more
Coriolis Pharma, a globally operating service provider for R&D and GMP drug product development, R&D and GMP analytics and sterile drug product manufacturing support, announced the launch of a U.S. entity that allows customers to combine the ...
read more
Sterling Pharma Solutions, a global contract development and manufacturing organization, announced a $3 million investment at its Germantown, WI facility, to expand its integrated antibody-drug conjugate (ADC) development and manufacturing ...
read more
Eurofins CDMO Alphora Inc. announced a significant expansion of its Drug Product Analytical Services Laboratory, increasing its footprint three-fold. Located in Mississauga, Canada, the expanded facility marks the addition of specialized equipment ...
read more
REPROCELL has been producing clinically relevant human induced pluripotent stem cells (hiPSCs) by controlling the process of donor recruitment to seed stock hiPSC and encompassing donor eligibility with different geographical regulatory agencies.
read more